Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

PURA and USMJ Confirm ALKM Order To Produce Sugar-Free EVERx CBD Sports Water

PURA, USMJ

Dallas, Texas--(Newsfile Corp. - May 3, 2021) - Puration, Inc. (OTC Pink: PURA) and North American Cannabis Holdings, Inc. today confirmed placing an order with Alkame Holdings, Inc. (OTC Pink: ALKM) to produce the first run of All-New Sugar-Free EVERx CBD Sports Water.

PURA and ALKM, together with North American Cannabis Holdings, Inc. (OTC Pink: USMJ) plan to soon announce the complete market introduction program for Sugar-Free EVERx CBD Sports Water.

Last year, PURA management committed to taking its cannabis technology and marketing experience and directing it toward a comprehensive initiative to crack the overall cannabis market wide open.

PURA initiated a new business plan focused first on hemp. PURA acquired 70 acres in Farmersville, Texas and introduced the Farmersville Hemp Brand.

Learn more about PURA's Farmersville Hemp Brand Program:

PURA Issues Farmersville Hemp Brand Update Discussing PAOG, ALKM and USMJ Partnerships Including Pharmaceutical, Cryptocurrency And Equity Initiatives

For more information on Puration, visit http://www.purationinc.com.

Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/82688



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today